• 1
    Black J, Hommel M, Snounou G, Pinder M. Mixed infections with Plasmodium falciparum and P. malariae and fever in malaria. Lancet 1994; 343:1095.
  • 2
    Maitland K, Williams TN, Newbold CI. Plasmodium vivax and P. falciparum: biological interactions and the possibility of cross-species immunity. Parasitol Today 1997; 13:22731.
  • 3
    Mason DP, McKenzie FE. Blood-stage dynamics and clinical implications of mixed Plasmodium vivax–Plasmodium falciparum infections. Am J Trop Med Hyg 1999; 61:36774.
  • 4
    Mayxay M, Pukrittayakamee S, Newton PN, White NJ. Mixed-species malaria infections in humans. Trends Parasitol 2004; 20:23340.
  • 5
    Snounou G, White NJ. The co-existence of Plasmodium: sidelights from falciparum and vivax malaria in Thailand. Trends Parasitol 2004; 20:3339.
  • 6
    Price RN, Simpson JA, Nosten F et al. Factors contributing to anemia after uncomplicated falciparum malaria. Am J Trop Med Hyg 2001; 65:61422.
  • 7
    Luxemburger C, Ricci F, Nosten F, Raimond D, Bathet S, White NJ. The epidemiology of severe malaria in an area of low transmission in Thailand. Tran R Soc Trop Med Hyg 1997; 91:25662.
  • 8
    Farouk SE, Mincheva-Nilsson L, Krensky AM, Dieli F, Troye-Blomberg M. Gamma delta T cells inhibit in vitro growth of the asexual blood stages of Plasmodium falciparum by a granule exocytosis-dependent cytotoxic pathway that requires granulysin. Eur J Immunol 2004; 34:224856.
  • 9
    Kassa D, Petros B, Mesele T, Hailu E, Wolday D. Characterization of peripheral blood lymphocyte subsets in patients with acute Plasmodium falciparum and P. vivax malaria infections at Wonji Sugar Estate, Ethiopia. Clin Vaccine Immunol 2006; 13:3769.
  • 10
    Worku S, Bjorkman A, Troye-Blomberg M, Jemaneh L, Farnert A, Christensson B. Lymphocyte activation and subset redistribution in the peripheral blood in acute malaria illness: distinct gamma delta+ T cell patterns in Plasmodium falciparum and P. vivax infections. Clin Exp Immunol 1997; 108:3441.
  • 11
    Lisse IM, Aaby P, Whittle H, Knudsen K. A community study of T lymphocyte subsets and malaria parasitaemia. Tran R Soc Trop Med Hyg 1994; 88:70910.
  • 12
    Jangpatarapongsa K, Sirichaisinthop J, Sattabongkot J et al. Memory T cells protect against Plasmodium vivax infection. Microbes Infect 2006; 8:6806.
  • 13
    Kabelitz D, Marischen L, Oberg HH, Holtmeier W, Wesch D. Epithelial defence by gamma delta T cells. Int Arch Allergy Imm 2005; 137:7381.
  • 14
    Kersten CM, McCluskey RT, Boyle LA, Kurnick JT. Escherichia coli and Pseudomonas aeruginosa induce expansion of V delta 2 cells in adult peripheral blood, but of V delta 1 cells in cord blood. J Immunol 1996; 157:161319.
  • 15
    Ferrick DA, Schrenzel MD, Mulvania T, Hsieh B, Ferlin WG, Lepper H. Differential production of interferon-gamma and interleukin-4 in response to Th1- and Th2-stimulating pathogens by gamma delta T cells in vivo. Nature 1995; 373:2557.
  • 16
    Garcia VE, Jullien D, Song M et al. IL-15 enhances the response of human gamma delta T cells to nonpeptide [correction of nonpetide] microbial antigens. J Immunol 1998; 160:43229.
  • 17
    Tsukaguchi K, De Lange B, Boom WH. Differential regulation of IFN-gamma, TNF-alpha, and IL-10 production by CD4(+) alpha beta TCR+ T cells and vdelta2(+) gammadelta T cells in response to monocytes infected with Mycobacterium tuberculosis-H37Ra. Cell Immunol 1999; 194:1220.
  • 18
    Wang L, Das H, Kamath A, Bukowski JF. Human V gamma 2V delta 2 T cells produce IFN-gamma and TNF-alpha with an on/off/on cycling pattern in response to live bacterial products. J Immunol 2001; 167:6195201.
  • 19
    Dieli F, Troye-Blomberg M, Ivanyi J et al. Granulysin-dependent killing of intracellular and extracellular Mycobacterium tuberculosis by Vgamma9/Vdelta2 T lymphocytes. J Infect Dis 2001; 184:10825.
  • 20
    Udomsangpetch R, Somsri S, Panichakul T et al. Short-term in vitro culture of field isolates of Plasmodium vivax using umbilical cord blood. Parasitol Int 2007; 56:659.
  • 21
    Cranmer SL, Magowan C, Liang J, Coppel RL, Cooke BM. An alternative to serum for cultivation of Plasmodium falciparum in vitro. Tran R Soc Trop Med Hyg 1997; 91:3635.
  • 22
    Tsuji M, Mombaerts P, Lefrancois L, Nussenzweig RS, Zavala F, Tonegawa S. Gamma delta T cells contribute to immunity against the liver stages of malaria in alpha beta T-cell-deficient mice. Proc Natl Acad Sci USA 1994; 91:3459.
  • 23
    Gonzalez-Aseguinolaza G, De Oliveira C, Tomaska M et al. alpha-galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria. Proc Natl Acad Sci USA 2000; 97:84616.
  • 24
    Schmieg J, Gonzalez-Aseguinolaza G, Tsuji M. The role of natural killer T cells and other T cell subsets against infection by the pre-erythrocytic stages of malaria parasites. Microbes Infect 2003; 5:499506.
  • 25
    Seixas EM, Langhorne J. gamma delta T cells contribute to control of chronic parasitemia in Plasmodium chabaudi infections in mice. J Immunol 1999; 162:283741.
  • 26
    Elloso MM, Van Der Heyde HC, Vande Waa JA, Manning DD, Weidanz WP. Inhibition of Plasmodium falciparum in vitro by human gamma delta T cells. J Immunol 1994; 153:118794.
  • 27
    McKenzie FE, Smith DL, O'Meara WP et al. Fever in patients with mixed-species malaria. Clin Infect Dis 2006; 42:171318.
  • 28
    Kwiatkowski D. Febrile temperatures can synchronize the growth of Plasmodium falciparum in vitro. J Exp Med 1989; 169:35761.
  • 29
    Long HY, Lell B, Dietz K, Kremsner PG. Plasmodium falciparum: in vitro growth inhibition by febrile temperatures. Parasitol Res 2001; 87:5535.
  • 30
    Nagao Y, Kimura-Sato M, Chavalitshewinkoon-Petmitr P et al. Suppression of Plasmodium falciparum by serum collected from a case of Plasmodium vivax infection. Malar J 2008; 7:113.
  • 31
    Wipasa J, Elliott S, Xu H, Good MF. Immunity to asexual blood stage malaria and vaccine approaches. Immunol Cell Biol 2002; 80:40114.
  • 32
    Alves FP, Durlacher RR, Menezes MJ, Krieger H, Silva LH, Camargo EP. High prevalence of asymptomatic Plasmodium vivax and Plasmodium falciparum infections in native Amazonian populations. Am J Trop Med Hyg 2002; 66:6418.
  • 33
    Ladeia-Andrade S, Ferreira MU, De Carvalho ME, Curado I, Coura JR. Age-dependent acquisition of protective immunity to malaria in riverine populations of the Amazon Basin of Brazil. Am J Trop Med Hyg 2009; 80:4529.
  • 34
    Kinyanjui SM, Mwangi T, Bull PC, Newbold CI, Marsh K. Protection against clinical malaria by heterologous immunoglobulin G antibodies against malaria-infected erythrocyte variant surface antigens requires interaction with asymptomatic infections. J Infect Dis 2004; 190:152733.
  • 35
    Osier FH, Fegan G, Polley SD et al. Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria. Infect Immun 2008; 76:22408.
  • 36
    Black CG, Barnwell JW, Huber CS, Galinski MR, Coppel RL. The Plasmodium vivax homologues of merozoite surface proteins 4 and 5 from Plasmodium falciparum are expressed at different locations in the merozoite. Mol Biochem Parasitol 2002; 120:21524.
  • 37
    Woodberry T, Minigo G, Piera KA et al. Antibodies to Plasmodium falciparum and Plasmodium vivax merozoite surface protein 5 in Indonesia: species-specific and cross-reactive responses. J Infect Dis 2008; 198:13442.
  • 38
    Fernandes AA, Carvalho LJ, Zanini GM et al. Similar cytokine responses and degrees of anemia in patients with Plasmodium falciparum and Plasmodium vivax infections in the Brazilian Amazon region. Clin Vaccine Immunol 2008; 15:6508.